Related Experiment Video
Updated: Aug 15, 2026
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
[Interstitial lung diseases of the interstitial-proliferative type]
M Schultz1, W Kühne, K Uschmann
1Institut für Pathologie des Bezirkskrankenhauses Magdeburg, DDR.
Zentralblatt Fur Allgemeine Pathologie U. Pathologische Anatomie
|January 1, 1988
Summary
This study details the interstitial-proliferative type of chronic interstitial pneumonia, distinguishing it as an independent condition or secondary to other diseases like lung cancer. Antibiotics show effectiveness in managing these inflammatory lung conditions.
Area of Science:
- Pulmonology
- Pathology
Context:
- Chronic interstitial pneumonia has been redefined, with a focus on the interstitial-proliferative subtype.
- Understanding the pathomorphological variations is crucial for accurate diagnosis and treatment.
Purpose:
- To describe the bioptic histopathological patterns of interstitial-proliferative lung disease in 15 patients.
- To correlate these histopathological findings with clinical symptoms.
- To differentiate between independent and secondary forms of this lung condition.
Summary:
- The study analyzed 15 cases of interstitial-proliferative lung disease, examining histopathological features.
- A key distinction was made between primary interstitial-proliferative pneumonia and secondary forms, often associated with lung cancer or observed in postmortem studies.
- Findings indicate that interstitial-proliferative inflammations can be effectively managed with antibiotic therapy.
Impact:
- Provides detailed histopathological insights into a specific type of interstitial lung disease.
- Clarifies the classification of interstitial-proliferative pneumonia, aiding in differential diagnosis.
- Suggests a therapeutic approach for managing interstitial-proliferative inflammations.
Related Concept Videos
01:17Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...